Content Type: Research Publications

Effect of Lawyer-Submitted Reports on Signals of Disproportional Reporting in the Food and Drug Administration’s Adverse Event Reporting System

March 15, 2026

Completion Rate and Reporting of Mandatory Pediatric Postmarketing Studies Under the US Pediatric Research Equity Act

March 15, 2026

A Systematic Review of Trial-Level Meta-Analyses Measuring the Strength of Association Between Surrogate End-Points and Overall Survival in Oncology

March 15, 2026

Patient-Centered Cancer Drug Development: Clinical Trials, Regulatory Approval, and Value Assessment

March 15, 2026

Implementation of a Health Plan Program for Switching From Analogue to Human Insulin and Glycemic Control Among Medicare Beneficiaries with Type 2 Diabetes

March 15, 2026

The Generic Drug Industry Embraces a Faster, Cheaper Pathway for Challenging Patents

March 15, 2026

New Drug Formulations and Their Respective Generic Entry Dates

March 15, 2026

Impact of the Priority Review Voucher Program on Drug Development for Rare Pediatric Diseases

March 15, 2026

Assessment of Use of Combined Dextromethorphan and Quinidine in Patients with Dementia or Parkinson Disease After US Food and Drug Administration Approval for Pseudobulbar Affect

March 15, 2026

Analysis of Proposed Medicare Part B to Part D Shift with Associated Changes in Total Spending and Patient Cost-Sharing for Prescription Drugs

March 15, 2026

Duration of Adjuvant Immunotherapy—Biologic, Clinical, and Economic Considerations

March 15, 2026

A Survey of Patients’ Perceptions of Pill Appearance and Responses to Changes in Appearance for Four Chronic Disease Medications

March 15, 2026